Professional patients in clinical trials present a growing challenge to the success and integrity of medical research. A professional patient is an individual who enrolls in multiple clinical trials, sometimes even within the same trial, or across different trials sponsored by different companies. Often, these professional patients participate across therapeutic areas and across sponsors, without disclosing their other trial participation.
This behavior introduces significant risks, as professional patients in clinical trials are often duplicate subjects in clinical trials, enrolling more than once or participating in several studies simultaneously.
The Risks of Professional Patients and Duplicate Subjects in Clinical Trials
The presence of professional patients in clinical trials and duplicate subjects in clinical trials can severely impact the outcome and reliability of research studies:
- Data Integrity Issues: Professional patients frequently misrepresent their medical history and participation status, leading to unreliable and invalid data that compromises clinical trial results.
- Increased Placebo Response Rates: Professional patients in clinical trials often artificially inflate placebo responses, making it difficult to accurately measure the true efficacy of investigational products.
- Clinical Trial Failure: Trials involving professional patients and duplicate subjects in clinical trials are at higher risk of failing to meet endpoints, leading to costly delays, repeat studies, or the abandonment of promising therapies.
- Patient Safety Concerns: Enrolling in multiple trials exposes professional patients to overlapping investigational treatments, significantly increasing the risk of adverse events, drug interactions, and other serious health consequences.
Verified Clinical Trials: The Solution for Professional Patients and Duplicate Subjects
Verified Clinical Trials (VCT) provides the global research community with the most effective protection against professional patients in clinical trials and duplicate subjects in clinical trials. VCT is the only solution that offers real-time detection and prevention at the time of screening, verifying a subject’s clinical trial participation history across sponsors and therapeutic areas.
Our comprehensive protection continues throughout the entire duration of the study, offering unparalleled safeguards for data quality and subject safety.
With Verified Clinical Trials, you can:
- Detect professional patients in clinical trials before enrollment
- Prevent duplicate subjects in clinical trials at the time of screening
- Protect the integrity of your data by ensuring genuine, compliant participation
- Safeguard subject safety by preventing simultaneous participation in multiple trials
- Reduce the risk of trial failure, costly delays, and regulatory scrutiny
Trusted by Leading Pharmaceutical Companies and Clinical Trial Sponsors
For more than a decade, Verified Clinical Trials has been the trusted partner for the world’s leading pharmaceutical companies, clinical trial sponsors, and contract research organizations. Our unmatched cross-sponsor and cross-therapeutic area protections have made VCT the industry gold standard for detecting and preventing professional patients and duplicate subjects in clinical trials.
There is no other solution like Verified Clinical Trials. Only VCT offers a global research subject registry capable of truly protecting your study from the threats posed by professional patients and duplicate subjects in clinical trials.
At Verified Clinical Trials, we are dedicated to safeguarding subject safety, preserving data integrity, and ensuring clinical trial success.
